Generally speaking, the adverse effects it brings are rational and will not hurt your body unconsciously. If you are not at ease or feel unwell now, you'd better consult the beauty department of a qualified big hospital and take corresponding measures. However, it is difficult to completely remove it from the body.
SFDA calls for a total ban on polyacrylamide hydrogel for injection.
-
Recently? The US Food and Drug Administration (SFDA) issued a notice to completely ban polyacrylamide hydrogel (for injection).
In this bulletin with the number [2006] 179 issued by the US Food and Drug Administration, SFDA indicated that there were suspicious adverse events and patient complaints during the use of polyacrylamide hydrogel (for injection), and SFDA Drug Evaluation Center re-evaluated the product after it went on the market, and concluded that polyacrylamide hydrogel (for injection) could not guarantee the safety of use.
Therefore, according to Article 32 of the Regulations on the Supervision and Administration of Medical Devices and Article 44 of the Measures for the Administration of Medical Device Registration, SFDA will completely stop producing, selling and using polyacrylamide hydrogel (for injection) in China from the date of announcement (April 30th).
It is understood that polyacrylamide hydrogel (for injection) is a kind of soft tissue filler, which is mainly used to fill various soft tissue depressions and defects on the body surface and increase tissue capacity, such as breast augmentation (breast augmentation), temporal breast augmentation, zygomatic breast augmentation, cheek breast augmentation and hip breast augmentation, as well as soft tissue filling and obstruction in the body.
According to the hospital director Cao. China once allowed the import of polyacrylamide hydrogel produced by Ukrainian company Intelfal to be sold and used in China as a long-term implanted medical device under the trade name "Intelfal". Since 2003, SFDA has started a comprehensive inventory of "Ingfarol", and banned the continued import and sale in China. Since then, only polyacrylamide hydrogel (for injection) produced by Jilin Hua Fu Company has been legally registered as a medical device.
It is reported that from 2002 to June 2005,1,National Adverse Drug Reaction Monitoring Center * * collected 183 adverse event monitoring reports related to polyacrylamide hydrogel (for injection). Among them, 182 cases were female, 1 cases were male, and 16 1 cases were used for breast augmentation. The main adverse reactions are inflammation, infection, induration, lump, hardness, deformation, displacement and residue. Among them, deformation 17 cases, displacement 16 cases, and implant residue 10 cases.
SFDA requires related product manufacturers to immediately stop producing and selling polyacrylamide hydrogel (for injection), take back all the products that have been sold, destroy the recovered and stocked products under the supervision of the provincial US Food and Drug Administration, and do a good job in handling the adverse events caused by the use of such products.
At the same time, SFDA requires local food and drug supervision departments to further strengthen the supervision and management of polyacrylamide hydrogel (for injection) products, and investigate and deal with illegal production, management and use of polyacrylamide hydrogel (for injection) products according to law.
Expert: Stop using polyacrylamide hydrogel to avoid secondary injury.
On April 30th this year, the US Food and Drug Administration terminated the use of polyacrylamide hydrogel (Ogilvy), which aroused widespread concern in society. Recently, however, some people who have received Ogilvy injections have been injured again in some informal beauty institutions. Zhao Zhenmin, vice president of the Plastic Surgery Hospital of China Academy of Medical Sciences, called for removal and plastic surgery in a regular plastic surgery institution with high medical level to avoid further injury.
Zhao Zhenmin said that polyacrylamide hydrogel has never been injected in a regular big hospital, but since the polyacrylamide hydrogel (including Ogilvy and Ingfarol) was launched, the hospital has started to treat patients who have problems after receiving polyacrylamide hydrogel injection.
At present, some beauty institutions in the society promise that polyacrylamide hydrogel can be sucked out again, which is painless and non-invasive. Zhao Zhenmin stressed that only through surgery can polyacrylamide hydrogel be removed, and patients should never believe the false advertisements of street beauty salons.
Luan Jie, director of the Breast Reconstruction Center of Plastic Surgery Hospital of China Academy of Medical Sciences, said that patients with local deformity, skin ulceration or pain after polyacrylamide hydrogel injection should be taken out in time. Patients without the above situation should not be overly nervous, and should go to a regular medical plastic surgery institution for examination.